Multiple myeloma: treatment options for an incurable disease.
Multiple myeloma remains a challenge for the treating physician, with extremely low complete response rates (5-10%) to conventional induction therapy. High dose therapy with autologous hematopoietic stem cell transplant results in improved response, event-free and overall survival and should be considered the standard of care for patients who are candidates for transplantation. Several newer treatment option are now available.
Division of Neoplastic Diseases and Related Disorders (Hematology-Oncology), Medical College of Wisconsin, Milwaukee 53226, USA.
S R
SR
Pandit
D006801:Humans; D009101:Multiple Myeloma / Q000150:complications / Q000473:pathology / Q000628:therapy*; D009367:Neoplasm Staging; D011379:Prognosis